Peter Llewellyn-Davies

Peter Llewellyn-Davies has over 25 years of experience in the pharmaceutical and biotechnology industry. Peter is currently a Non-Executive Director at Shield Therapeutics.

Previously, they were with BIOTECH AUSTRIA, APEIRON Biologics AG, Shield Therapeutics plc, and Immunocore. At Medigene AG, they were responsible for business development, finance, HR, investor and public relations, IP, IT and strategic investments.

Peter also serves as the Vice Chairman of 4basebio AG, and is a Board member / Non executive director of Catherex Inc.